Professor Emma Crosbie, Cancer Prevention and Early Detection Co-Theme Lead at the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), Honorary Consultant in Gynaecological Oncology at Manchester University NHS Foundation Trust (MFT), and we’re very proud to say, President of Peaches Womb Cancer Trust has been awarded a prestigious NIHR Research Professorship.
Professor Crosbie has developed a triage tool that uses routinely collected clinical data and a novel biomarker to predict risk of endometrial cancer in women with postmenopausal bleeding. If accurate when tested, this tool would reduce the number of women needing invasive diagnostics by half, without missing any cancers.
The aim of Emma’s NIHR Professorship is to establish whether the endometrial cancer triage tool is accurate, works for everyone, what the cost implications are, what women and doctors think about it and to develop a clinician-facing online digital calculator for use in the NHS.
Professor Crosbie, who is also a Professor in Gynaecological Oncology at The University of Manchester (UoM), said:
“I am delighted and honoured to receive this Research Professorship from the NIHR, and I look forward to dedicating my time over the next five years to developing and refining this important research question, which has the potential to benefit thousands of women across the country every year.
If successful and implemented into clinical practice, this non-invasive, cost-effective, and accurate detection tool could improve patient care by identifying those at high-risk of endometrial cancer, while sparing many healthy women from unnecessary invasive tests.”
Read more on the Manchester University NHS Foundation Trust website.
